| 2023-11-06 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-11.42美元,归母净利润-26.8亿美元,同比去年增长-5135.27%
|
| 2023-11-06 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.04美元,归母净利润-832.4万美元,同比去年增长99.69%
|
| 2023-08-08 |
详情>>
业绩披露：
2023年中报每股收益0.09美元,归母净利润2015.90万美元,同比去年增长101.03%
|
| 2023-03-06 |
详情>>
股本变动：
变动后总股本23521.96万股
|
| 2022-08-09 |
详情>>
业绩披露：
2022年中报每股收益-8.35美元,归母净利润-19.57亿美元,同比去年增长-7621.52%
|
| 2022-05-19 |
复牌提示：
2022-05-18 12:39:33 停牌，复牌日期 2022-05-18 12:44:33
|
| 2022-05-06 |
详情>>
业绩披露：
2022年一季报每股收益-0.31美元,归母净利润-7197.4万美元,同比去年增长-273.33%
|
| 2022-05-05 |
财报披露：
美东时间 2022-05-05 盘后发布财报
|
| 2022-04-28 |
股东大会：
将于2022-06-09召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, eight members to our Board of Directors to serve until the next Annual General Meeting of Shareholders;
2.To approve, on an advisory basis, the compensation of our named executive officers (say-on-pay);
3.To renew the Board’s existing authority to issue shares under Irish law;
4.To renew the Board’s existing authority to opt-out of statutory pre-emption rights under Irish law;
5.To approve the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2022 and to authorize the Board of Directors, acting through the Audit & Finance Committee, to determine the independent registered public accounting firm’s remuneration;
6.To act upon such other matters as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2022-03-01 |
详情>>
业绩披露：
2019年年报每股收益-1.87美元,归母净利润-4.23亿美元,同比去年增长59.03%
|
| 2022-03-01 |
详情>>
业绩披露：
2021年年报每股收益-2.63美元,归母净利润-6.13亿美元,同比去年增长-433.39%
|
| 2021-11-05 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-0.22美元,归母净利润-5118.3万美元,同比去年增长-179.23%
|
| 2021-11-05 |
详情>>
业绩披露：
2020年三季报(累计)每股收益0.28美元,归母净利润6460.10万美元,同比去年增长131.67%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-06 |
详情>>
业绩披露：
2021年中报每股收益0.11美元,归母净利润2602.40万美元,同比去年增长-81.48%
|
| 2021-05-07 |
详情>>
业绩披露：
2021年一季报每股收益0.18美元,归母净利润4152.40万美元,同比去年增长-68.04%
|
| 2021-04-29 |
股东大会：
将于2021-06-10召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, eight members to our Board of Directors to serve until the next Annual General Meeting of Shareholders;
2.To approve, on an advisory basis, the compensation of our named executive officers (say-on-pay);
3.To renew the Board’s existing authority to issue shares under Irish law;
4.To renew the Board’s existing authority to opt-out of statutory pre-emption rights under Irish law;
5.To approve the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2021 and to authorize the Board of Directors, acting through the Audit & Finance Committee, to determine the independent registered public accounting firm’s remuneration; 6.To act upon such other matters as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2021-02-26 |
详情>>
业绩披露：
2020年年报每股收益0.80美元,归母净利润1.84亿美元,同比去年增长143.52%
|
| 2020-04-28 |
股东大会：
将于2020-06-11召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, eight members to our Board of Directors to serve until the next Annual General Meeting of Shareholders;
2.To approve, on an advisory basis, the compensation of our named executive officers (say-on-pay);
3.To approve the Endo International plc Amended and Restated 2015 Stock Incentive Plan;
4.To renew the Board’s existing authority to issue shares under Irish law;
5.To renew the Board’s existing authority to opt-out of statutory pre-emption rights under Irish law;
6.To approve the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2020 and to authorize the Board of Directors, acting through the Audit Committee, to determine the independent registered public accounting firm’s remuneration;
7.To act upon such other matters as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2019-04-29 |
股东大会：
将于2019-06-11召开股东大会
会议内容 ▼▲
- (1)To elect, by separate resolutions, seven members to our Board of Directors to serve until the next Annual General Meeting of Shareholders;
(2)To approve, on an advisory basis, the compensation of our named executive officers (say-on-pay);
(3)To approve the Endo International plc Amended and Restated 2015 Stock Incentive Plan;
(4)To renew the Board’s existing authority to issue shares under Irish law;
(5)To renew the Board’s existing authority to opt-out of statutory pre-emption rights under Irish law;
(6)To approve the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2019 and to authorize the Board of Directors, acting through the Audit Committee, to determine the independent registered public accounting firm’s remuneration;
(7)To act upon such other matters as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2018-04-27 |
股东大会：
将于2018-06-07召开股东大会
会议内容 ▼▲
- (1)To elect, by separate resolutions, eight members to our Board of Directors to serve until the next Annual General Meeting of Shareholders;
(2)To approve the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2018 and to authorize the Board of Directors, acting through the Audit Committee, to determine the independent registered public accounting firm’s remuneration;
(3)To approve, on an advisory basis, the compensation of our named executive officers (say-on-pay);
(4)To approve the Endo International plc Amended and Restated 2015 Stock Incentive Plan;
(5)To renew the Board’s existing authority to issue shares under Irish law;
(6)To renew the Board’s existing authority to opt-out of statutory pre-emption rights under Irish law;
(7)To act upon such other matters as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2017-04-28 |
股东大会：
将于2017-06-08召开股东大会
会议内容 ▼▲
- (1)To elect, by separate resolutions, nine members to our Board of Directors to serve until the next Annual General Meeting of Shareholders;
(2)To approve the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2017 and to authorize the Board of Directors, acting through the Audit Committee, to determine the independent registered public accounting firm’s remuneration;
(3)To approve, on an advisory basis, the compensation of our named executive officers (say-on-pay);
(4)To approve, on an advisory basis, the frequency of soliciting an advisory say-on-pay vote (say-on-frequency);
(5)To approve the amendment of the Company’s Memorandum of Association;
(6)To approve the amendment of the Company’s Articles of Association;
(7)To approve the amendment of the Company’s Amended and Restated 2015 Stock Incentive Plan;
(8)To act upon such other matters as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2016-04-28 |
股东大会：
将于2016-06-09召开股东大会
会议内容 ▼▲
- 1.To elect by separate resolutions nine directors, representing all of the members of the Board of Directors of the Company, to serve until the next Annual Meeting;
2.To approve the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditors for the year ending December 31, 2016 and to authorize the Audit Committee of the Board of Directors to determine the auditors’ remuneration;
3.To conduct an advisory vote on the compensation of our named executive officers;
4.To approve the amendment of the Company’s Memorandum of Association;
5.To approve the amendment of the Company’s Articles of Association;
6.To approve the amendment of the Company’s 2015 Stock Incentive Plan;
7.To act upon such other matters as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2015-04-29 |
股东大会：
将于2015-06-09召开股东大会
会议内容 ▼▲
- 1. To elect by separate resolutions nine directors, representing all of the members of the Board of Directors of the Company, to serve until the next Annual Meeting;
2. To approve the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditors for the year ending December 31, 2015 and to authorize the Audit Committee of the Board of Directors to determine the Auditors’ remuneration;
3. To conduct an advisory vote on the compensation of our named executive officers;
4. To approve the Company’s 2015 Stock Incentive Plan;
5. To act upon such other matters as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2015-03-10 |
详情>>
内部人交易：
Farhat Camille股份减少8650.00股
|
| 2014-04-29 |
股东大会：
将于2014-06-10召开股东大会
会议内容 ▼▲
- 1. To elect nine directors, representing all of the members of the Board of Directors of the Company, to serve until the next Annual Meeting of Shareholders;
2. To approve the appointment of Deloitte & Touche as the Company’s independent auditors for the year ending December 31, 2014; and to authorize the Audit Committee of the Board of Directors to determine the Auditors’ remuneration;
3. To conduct an advisory vote on the compensation of our named executive officers;
4. To approve the Amended and Restated Employee Stock Purchase Plan;
5. To act upon such other matters as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|